Virologic Response / Virologic Control /
Virologic Suppression

Most Patients with Highly Drug-resistant HIV Treated with an Incompletely Suppressive Regimen Maintain Durable Immunological and Virological Responses despite Acquiring New Resistant Mutations - 10/05/07

Week 8 Response Predicts Week 48 Virological Response to Tipranavir/ritonavir in the RESIST Studies - 8/28/07

After 4 Years of Viral Suppression with HAART, HIV Rebound Rates in Patients with Multiple Prior Treatment Failures Resemble Those in Individuals with No Prior Failure    - 7/07/07

HIV Suppression with HAART Preserves Cognitive Function in Patients with AIDS    - 6/19/07

Most Patients on Lopinavir/Ritonavir-based HAART Achieve Complete Virologic Suppression with Adherence Rates Less Than 95%    - 6/01/07

Switching from PIs to Nevirapine Usually Safe and Maintains Virological Suppression   12/05/06

Tenofovir + Efavirenz vs Tenofovir + Efavirenz + 3TC: The COOL Trial   10/06/06

Increased Clinical Events in Patients with Virological Suppression but Persistent CD4 Count below 200 Cells/mm3   9/29/06

Continued HIV Suppression after Regimen Simplification with Atazanavir Monotherapy - 9/01/06

Atazanavir with or without Ritonavir Shows High Rate of Virologic Response - 3/17/06

Early Virologic Non Response to Tenofovir, Abacavir and Lamivudine - 11/30/05

Lopinavir/Ritonavir as Monotherapy for Maintenance of HIV Viral Suppression: 48-Week Results - 10/28/05

Discordant Immunologic and Virologic Responses to HAART Are Associated with Increased Risk of Death and Poor Adherence to Therapy - 11/02/05

Is There a Future for Structured Treatment Interruption in HIV Patients Failing on HAART? - 9/28/05

Durable Virological Suppression Improves Survival in Neurocognitively Impaired Patients on HAART - 9/28/05

Switching from a Protease Inhibitor (PI) to Nevirapine Is as Effective as Continuing with PI for Viral Suppression and Improves Lipodystrophy - 9/23/05

A Pilot Study of Lopinavir/ritonavir Maintenance Monotherapy after Successful Viral Suppression with Standard HAART - 3/30/05